|Bid||9.45 x 0|
|Ask||9.48 x 0|
|Day's Range||9.36 - 9.94|
|52 Week Range||5.94 - 15.50|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||10.12|
Canopy Growth's Acreage Acquisition Boosts Sentiment(Continued from Prior Part)ACB, IIPR, and OGI gain On April 18, in the first half of the trading session, Aurora Cannabis (ACB) was trading up 1% while Innovative Industrial Properties (IIPR)
CGC, HEXO, CTST Moving Higher TodayCannabis sector gains Today, the Horizons Marijuana Life Sciences ETF (HMMJ) gained about 0.3% and the ETFMG Alternative Harvest ETF (MJ) gained about 0.3% in the first half of the trading session. However, the
PALM BEACH, Florida , April 17, 2019 /CNW/ -- The projections for the legal & CBD cannabis markets seem to get higher with every new arrival and big box and brick & mortar retailers of all sizes have taken ...
TLRY, CGC, ACB Snap Out of Their Losing Streaks(Continued from Prior Part)Aphria trading higher Aphria (APHA) lost about 14% in yesterday’s trading session after it reported its earnings. The company wrote off 50 million Canadian dollars relating
Canopy Growth Continues to Expand amid Market WeaknessMarket weaknessThe cannabis sector has weakened recently. Most cannabis stocks ended March in negative territory, and this trend has worsened in April. Tilray (TLRY) and CannTrust (CTST) have
Aphria Declines, Other Cannabis Stocks FollowAphria fellEarly on April 15, Aphria (APHA) released its third-quarter earnings, which missed the expectations. The company’s losses widened to 108 million Canadian dollars due to a write-off
PALM BEACH, Florida, April 15, 2019 /CNW/ -- A Green Flower cannabis industry article started off with this amazing statement: "The cannabis market is booming these days, now operating legally in a number of states and countries across the globe." Another industry publication, the Marijuana Business Daily, supported this proposition, based on more states in the U.S. and more countries in the world, legalizing the industry. The Green Flower article also mentioned: "(the) U.S. cannabis market to surpass $24 billion by 2025" and"Another study with projections for 2021 was conducted by the Brightfield Group.
Cannabis Sector Was Disappointing Last Week(Continued from Prior Part)Sectoral weakness Last week, Cronos Group (CRON) ended in the negative territory. Cronos Group had a weekly decline of 7.4%, which was in line with the broader sectoral weakness.
Just like industry peers, CannTrust Holdings Inc. (TSX:TRST)(NYSE:CTST) reported impressive revenue growth but disappointing bottom-line results. The stock recently tumbled and might remain in negative territory unless profitability improves.
What It Means for Canopy Growth to Be Part of S&P/TSX 60 Index(Continued from Prior Part)Funds from funds With the inclusion in the S&P/TSX 60 Index, Canopy Growth (WEED) now becomes open to funds that are only focused on index investing as a
CGC, CRON, and GTBIF Reverse Their Falling Streaks on April 12(Continued from Prior Part)Breaking the losing streak Cannabis stocks have recently experienced weakness amid concerns surrounding a global slowdown and companies missing their earnings
Green Thumb Industries: Analysts' Views in April(Continued from Prior Part)Lower valuations Green Thumb Industries (GTBIF) has experienced selling pressure in April. However, the company isn’t alone. The overall cannabis sector faced weakness. Most
NEW YORK, April 12, 2019 /CNW/ -- Canadian cannabis companies have recently begun launching operations within the U.S. due to the attractive growth opportunity the country presents. Furthermore, as they expand operations around the country, cannabis-based companies are also looking to list either on the New York Stock Exchange or the Nasdaq Exchange, the two largest exchanges in the world. As legalization efforts continue to ramp up, more and more companies are listing or uplisting onto these major exchanges.
What's Attorney General Barr's Take on Marijuana Legalization?(Continued from Prior Part)US marijuana lawsThe US is one of the most anticipated markets for companies such as Canopy Growth (WEED), Aurora Cannabis (ACB), CannTrust (CTST), KushCo
PALM BEACH, Florida, April 11, 2019 /CNW/ -- Since the 1960's, all eyes have been on California (Berkley, San Francisco, etc.) when it comes to marijuana. In fashion, films, societal changes and legalized pot… California has always seemed to be in the lead. In California, cannabis is not only legal, but you can also have it delivered to your home. And the company that did most of those deliveries issued a report based on data they collected from 450,000 buyers and about 4,000 survey respondents. The delivery company's name is Eaze and here is what their report said: "2018 was a monumental year for the cannabis industry.
Do Cannabis Stocks Look Cheap at These Valuations?(Continued from Prior Part)Comparing valuation multiples As of April 9, the median forward EV-to-sales multiple of our select group of 12 cannabis players was about 6.2x. The popular cannabis stocks
Do Cannabis Stocks Look Cheap at These Valuations?(Continued from Prior Part)Trading compsThe cannabis sector’s median forward EV-to-EBITDA (enterprise value-to-earnings before interest, tax, depreciation, and amortization) multiple was 23.6x,
VAUGHAN, ON, April 10, 2019 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST, NYSE: CTST) is pleased to announce that it has launched three new cannabis extract formulations to meet the growing demand for oil-based products. The new formulations are designed to fill previously unmet needs within the Canadian medical market, identified through market research and the Company's long-standing relationships with thousands of medical cannabis patients and their healthcare practitioners.
CTST, HEXO, and APHA: Cannabis Stocks Fall on April 9(Continued from Prior Part)Sector declinesOverall, the cannabis sector fell on April 9. The Horizon Marijuana Life Sciences ETF (HMMJ) lost almost 2.5% of its value by mid-day, while the ETFMG
NEW YORK, April 9, 2019 /CNW/ -- Nearly 20% of U.S. adults suffer from chronic pain, while 8% are diagnosed with high-impact chronic pain, according to the National Institute of Health. Researchers from the Centers for Disease Control and Prevention (CDC), National Institutes of Health, Stanford Division of Pain Medicine, Kaiser Permanente, and Yale University concluded that chronic pain problems actually limited certain daily tasks in patients' lives. Traditionally, most patients who suffer from chronic pain are prescribed opioids like hydrocodone and oxycodone in order to suppress the pain.